Dermata Therapeutics Inc. (DRMA)
undefined
undefined%
At close: undefined
1.09
-0.91%
After-hours Dec 13, 2024, 05:31 PM EST

Dermata Therapeutics Inc. Forcast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for DRMA stock have an median target of 6, with a low estimate of 6 and a high estimate of 6. The median target predicts an increase of 445.45% from the current stock price of 1.10.

Analyst Consensus: Buy
Target Low Average Median High
Price $6 $6 $6 $6
Change 445.45% 445.45% 445.45% 445.45%

AI Analyst Report

According to 1 stock analyst, the rating for Dermata Therapeutics Inc. is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.

Rating Aug 24
Strong Buy 0
Buy 1
Hold 0
Sell 0
Strong Sell 0
Total 1

Financial Forecast this Year

Revenue This Year
n/a
Revenue Next Year
0
from 0
Increased by -%
EPS This Year
-15.24
from -40.18
Increased by 62.1%
EPS Next Year
-3.87
from -15.24
Increased by 74.6%